Quantum company IonQ has partnered with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate next-generation therapeutics using hybrid quantum and quantum-AI technologies.  The collaboration will initially focus on areas including bioprocess optimisation, disease-modelling workflows, and quantum-enhanced simulation to support the design and manufacturing of advanced therapies. By bringing together CCRM’s expertise in next-generation therapeutic innovation and IonQ’s understanding of cutting-edge quantum […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!